help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

First published online on November 29, 2007
This version published online on January 24, 2008
Endocrine Reviews, doi:10.1210/er.2007-0015
Endocrine Reviews, doi:10.1210/er.2007-0015
Endocrine Reviews 0 (2008): 200700152-
Copyright © 2008 by The Endocrine Society
This Article
Right arrow Final Manuscript (PDF)
Right arrow All Versions of this Article:
29/1/42    most recent
Final Manuscript
Author Manuscript
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eizirik, D. L.
Right arrow Articles by Cnop, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eizirik, D. L.
Right arrow Articles by Cnop, M.

Submitted on May 29, 2007
Accepted on November 6, 2007

The Role for Endoplasmic Reticulum Stress in Diabetes Mellitus

Décio L. Eizirik*, Alessandra K. Cardozo, and Miriam Cnop

Laboratory of Experimental Medicine (D.L.E., A.K.C., M.C.), Université Libre de Bruxelles, Division of Endocrinology (M.C.), Erasmus Hospital, 1070 Brussels, Belgium

* To whom correspondence should be addressed. E-mail: deizirik{at}ulb.ac.be.

Accumulating evidence suggests that endoplasmic reticulum (ER) stress plays a role in the pathogenesis of diabetes, contributing to pancreatic {beta}-cell loss and insulin resistance. Components of the unfolded protein response (UPR) play a dual role in {beta}-cells, acting as beneficial regulators under physiological conditions or as triggers of {beta}-cell dysfunction and apoptosis under situations of chronic stress. Novel findings suggest that "what makes a {beta}-cell a {beta}-cell", i.e., its enormous capacity to synthesize and secrete insulin, is also its Achilles heel, rendering it vulnerable to chronic high glucose and fatty acid exposure, agents that contribute to {beta}-cell failure in type 2 diabetes. In this review, we address the transition from physiology to pathology, namely how and why the physiological UPR evolves to a proapoptotic ER stress response and which defenses are triggered by {beta}-cells against these challenges. ER stress may also link obesity and insulin resistance in type 2 diabetes. High fat feeding and obesity induce ER stress in liver, which suppresses insulin signaling via c-Jun N-terminal kinase activation. In vitro data suggest that ER stress may also contribute to cytokine-induced {beta}-cell death. Thus, the cytokines IL-1{beta} and interferon-{gamma}, putative mediators of {beta}-cell loss in type 1 diabetes, induce severe ER stress through, respectively, NO-mediated depletion of ER calcium and inhibition of ER chaperones, thus hampering {beta}-cell defenses and amplifying the proapoptotic pathways. A better understanding of the pathways regulating ER stress in {beta}-cells may be instrumental for the design of novel therapies to prevent {beta}-cell loss in diabetes.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society